- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Medrad mobilizes MRI injector
Spectris has gone mobile. The injector of MRI contrast media has been adapted by Medrad for use in the tight quarters of MRI trailers. This configuration has a space-saving base-plate that secures the injector to the wall and a transportation clamp that
Spectris has gone mobile. The injector of MRI contrast media has been adapted by Medrad for use in the tight quarters of MRI trailers. This configuration has a space-saving base-plate that secures the injector to the wall and a transportation clamp that also secures the injector head to the wall for easy and safe transport. It is compatible with the four major mobile trailer manufacturers: Calumet Coach, Medical Coaches, AK Associates, and Ellis & Watts. The mobile configuration is currently available in North America and will roll out in Europe, Latin America, and Japan at a later date.
© 2001 Miller Freeman Inc.
3/28/01, Issue # 1506, page 6.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
